Vanberra Signal
Free trial

Igyxos

Curated by Signal

Developer of antibodies for the treatment of infertility

Life Sciences Technologyigyxos.com

Overview

Igyxos is developing treatments for female and male infertility. The company is using monoclonal antibodies to shift hormonal imbalances which cause infertility. The company's antibodies would potentiate the bioactivity of gonadotropins, which is a key hormone for the fertilization. It is also focused on assisted reproductive technology.

Key facts

Founded
2017
Headquarters
Nouzilly, France
Stage
Sign up to view
Industry
Life Sciences Technology

Business model

2 products and services
Sign up to view

Contact

Primary office
Sign up to view
Email
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • Circles

    Provider of solutions for women's health and beauty, with a focus on hormone balance

    Life Sciences TechnologyParis, France

  • InstaDreamer

    Provider of smart biosensor band for sleep monitoring

    Life Sciences TechnologyFrance

  • Mayday SOS

    Application based safety management platform provider

    Life Sciences TechnologyMarseille, France

About Igyxos

What does Igyxos do?

Igyxos is developing treatments for female and male infertility.

Where is Igyxos headquartered?

Igyxos is headquartered in Nouzilly, France.

When was Igyxos founded?

Igyxos was founded in 2017.

Which sector is Igyxos in?

Igyxos operates in Life Sciences Technology.

Who are Igyxos's competitors?

Companies similar to Igyxos include Circles, InstaDreamer, and Mayday SOS.